Robert E. Litman

Dopamine D2 receptor occupancy of lumateperone (ITI-007): a Positron Emission Tomography Study in patients with schizophrenia

Kimberly E. Vanover, Robert E. Davis, Yun Zhou et al. · Neuropsychopharmacology · 2018 · 238 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Investigations of Equivocal Suicides

Robert E. Litman · JAMA · 1963 · 181 citations

Medicine, Psychiatry, Forensic Psychiatry +12

Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study

Michelle Kramer, Robert E. Litman, David Hough et al. · The International Journal of Neuropsychopharmacology · 2009 · 178 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia

Jeffrey A. Lieberman, Kelly Papadakis, John G. Csernansky et al. · Neuropsychopharmacology · 2008 · 163 citations

Medicine, Pharmacology, Psychiatry +13

Idazoxan and Response to Typical Neuroleptics in Treatment-Resistant Schizophrenia

Robert E. Litman, Tung‐Ping Su, William Z. Potter et al. · The British Journal of Psychiatry · 1996 · 134 citations

Medicine, Pharmacology, Psychiatry +17